Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 11, Pages 2305
Publisher
MDPI AG
Online
2017-11-03
DOI
10.3390/ijms18112305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
- (2017) Gerardo Botti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
- (2017) Nobumoto Tomioka et al. Breast Cancer
- Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells
- (2017) Weibin Wu et al. PLoS One
- Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer
- (2016) Aiyu Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting the androgen receptor in triple-negative breast cancer
- (2016) Ayca Gucalp et al. CURRENT PROBLEMS IN CANCER
- Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells
- (2016) K Tominaga et al. ONCOGENE
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Androgen receptor status is highly conserved during tumor progression of breast cancer
- (2015) André Grogg et al. BMC CANCER
- Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
- (2015) W. T. Iams et al. CLINICAL CANCER RESEARCH
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
- (2015) Murugan Kalimutho et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Triple negative breast cancer: looking for the missing link between biology and treatments
- (2015) Giuseppe Palma et al. Oncotarget
- Biologic Roles of Estrogen Receptor-βand Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer
- (2015) Nalo Hamilton et al. Biomed Research International
- Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease
- (2015) Valerie N. Barton et al. Hormones & Cancer
- Insulin/Insulin-Like Growth Factors in Cancer: New Roles for the Aryl Hydrocarbon Receptor, Tumor Resistance Mechanisms, and New Blocking Strategies
- (2015) Travis B. Salisbury et al. Frontiers in Endocrinology
- Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
- (2015) Kunal Amratlal Lodhia et al. Frontiers in Oncology
- Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
- (2014) Jung Eun Choi et al. ANNALS OF SURGICAL ONCOLOGY
- Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
- (2014) María D Cuenca-López et al. BMC CANCER
- AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
- (2014) Yassine Rechoum et al. BREAST CANCER RESEARCH AND TREATMENT
- Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells
- (2014) M Mancini et al. BRITISH JOURNAL OF CANCER
- Subtyping of triple-negative breast cancer: Implications for therapy
- (2014) Vandana G. Abramson et al. CANCER
- Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
- (2014) Pierluigi Gasparini et al. PLoS One
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer
- (2013) Cynthia X. Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-negative breast cancer
- (2013) Kim M. Hirshfield et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Insulin and IGFs in Obesity-Related Breast Cancer
- (2013) Valentina Belardi et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
- (2013) Aye Aye Thike et al. MODERN PATHOLOGY
- Two Is Better Than One: Combining IGF1R and MEK Blockade as a Promising Novel Treatment Strategy Against KRAS -Mutant Lung Cancer
- (2013) Ron Chen et al. Cancer Discovery
- Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
- (2013) J. M. Balko et al. Cancer Discovery
- Expression of androgen receptors in triple negative breast carcinomas
- (2012) Ivana Mrklić et al. ACTA HISTOCHEMICA
- The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
- (2012) M. Pollak CLINICAL CANCER RESEARCH
- Differential Effect of Growth Factors on Invasion and Proliferation of Endocrine Resistant Breast Cancer Cells
- (2012) Maitham A. Khajah et al. PLoS One
- Expression and clinical significance of androgen receptor in triple negative breast cancer
- (2012) Xiang Luo et al. Chinese Journal of Cancer
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells
- (2011) A. E. Richardson et al. GROWTH FACTORS
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
- (2011) Dabei Tang et al. MEDICAL ONCOLOGY
- Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Jiehua He et al. MEDICAL ONCOLOGY
- Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
- (2011) Erin R. King et al. Recent Patents on Anti-Cancer Drug Discovery
- High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
- (2010) B. C. Litzenburger et al. CLINICAL CANCER RESEARCH
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now